ESHRE 2025 - Main programme


Please take the 
time zone differences into account! Times are shown in CE(S)T – Central European (Summer) Time.

>> Monday >> Tuesday >> Wednesday


Tuesday 01 July 2025

08:30 - 09:30
Invited session 15: Incorporating artificial intelligence in clinical practice - are we there yet?
08:30 - 08:50
Streamlining the workflow of fertility treatments using AI
Ariel Hourvitz, Israel
08:50 - 09:00
Discussion
09:00 - 09:20
Leveraging artificial intelligence to enhance ovarian stimulation
Eduardo Hariton, U.S.A.
09:20 - 09:30
Discussion

08:30 - 09:30
Invited session 16: When it lies in the genes: can we predict age at natural menopause and modulate reproductive life-span?
08:30 - 08:50
Monogenic diagnostics and polygenic screening of natural age at menopause
Aspasia Destouni, Greece
08:50 - 09:00
Discussion
09:00 - 09:20
Developing new molecular therapeutic strategies to modulate ovarian reserve
Francesca Duncan, U.S.A.
09:20 - 09:30
Discussion

08:30 - 09:30
Invited session 17: Recurrent pregnancy loss: bridging the gap between research and treatment
08:30 - 08:50
Tracing the genetic threads of (recurrent) pregnancy loss
Karina Banasik, Denmark
08:50 - 09:00
Discussion
09:00 - 09:20
Tailoring treatment to ploidy: personalized approaches in (recurrent) pregnancy loss care
Rima Dhillon-Smith, United Kingdom
09:20 - 09:30
Discussion

08:30 - 09:30
Invited session 18: The role of robotic surgery in reproductive medicine
Chairs
Chair invited, but not yet confirmed
Chair invited, but not yet confirmed
08:30 - 08:50
The use of robotic surgery in the management of uterine fibroids
Arnold Advincula, U.S.A.
08:50 - 09:00
Discussion
09:00 - 09:20
The value of robotic surgery in the management of endometriosis
Liliana Mereu, Italy
09:20 - 09:30
Discussion

08:30 - 09:30
Invited session 19: Debate: Commercialisation is a necessity for ART to flourish
08:30 - 08:45
Pro
Rita Vassena, Spain
08:45 - 09:00
Con
Lucy van de Wiel, United Kingdom
09:00 - 09:05
Rebuttal
Rita Vassena, Spain
09:05 - 09:10
Rebuttal
Lucy Frith, United Kingdom
09:10 - 09:30
Discussion

08:30 - 09:30
Invited session 20: Parenting assessment and the access to reproductive medicine
08:30 - 08:50
Child welfare assessments and the regulation of access to publicly funded fertility treatment
Judith Lind, Sweden
08:50 - 09:00
Discussion
09:00 - 09:20
Investigating new perceptions in fertility care access in Ireland
Sorca O Brien, Ireland
09:20 - 09:30
Discussion

08:30 - 09:30
Poster discussion session

09:30 - 10:00
Coffee break

10:00 - 11:30
5 parallel selected oral communications sessions

10:00 - 13:00
Invited session 21: Live surgery session

10:00 - 11:30
Poster discussion session

11:45 - 13:05
Invited session 22: European and Global ART monitoring

11:45 - 12:45
Invited session 23: Zooming into embryonic cells
11:45 - 12:05
Studying embryos at single-cell resolution: implications for reproductive medicine
Antonio Scialdone, Germany
12:05 - 12:15
Discussiion
12:15 - 12:35
Cellular bases of cell polarity and their role in blastocyst formation
Jean-Léon Maître, France
12:35 - 12:45
Discussion

11:45 - 12:45
Invited session 24: Variation in infertility rates, monitoring and treatment across the globe
11:45 - 12:05
How reproductive imaginaries shape monitoring and treatment of infertility
Jasmine Fledderjohann, United Kingdom
12:05 - 12:15
Discussion
12:15 - 12:35
Changing reproductive behaviours and infertility
Tomas Sobotka, Austria
12:35 - 12:45
Discussion

11:45 - 12:45
Selected oral communication session

11:45 - 12:45
Poster discussion session

13:00 - 14:00
Lunch break

14:00 - 15:00
Invited session 25: MHR Symposium

14:00 - 15:00
Invited session 26: Exchange session

14:00 - 15:00
Invited session 27: Genetics cause of male infertility : where are we in 2025?
Chair
Chair invited, but not yet confirmed
14:00 - 14:20
From chromosome to gene disorder in human spermatogenic failure 
Csilla Gabriella Krausz, Italy
14:20 - 14:30
Discussion
14:30 - 14:50
Genetics of teratozoospermia
Pierre Ray, France
14:50 - 15:00
Discussion

14:00 - 15:00
Invited session 28: Patient session

14:00 - 15:00
Invited session 29: Debate: oral GnRH antagonist for endometriosis
14:00 - 14:15
Pro
Marie-Madeleine Dolmans, Belgium
14:15 - 14:30
Cons
Paolo Vercellini, Italy
14:30 - 14:35
Rebuttal
Marie-Madeleine Dolmans, Belgium
14:35 - 14:40
Rebuttal
Paolo Vercellini, Italy
14:40 - 15:00
Discussion

14:00 - 15:00
Poster discussion session

15:15 - 16:30
6 parallel selected oral communications sessions

15:15 - 16:30
Poster discussion session

16:30 - 17:00
Coffee break

17:00 - 18:00
5 parallel selected oral communications sessions

17:00 - 18:00
Poster discussion session

18:00 - 19:00
Annual General Assembly